News
The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...
The biotech Gilead Sciences has been the best-performing healthcare stock in the S&P 500 by far over the past 12 months. Its ...
4h
Cryptopolitan on MSNTether deepens investment in Juventus as part of broader diversification strategyStablecoin issuer Tether has increased its ownership stake in Italian Serie A football club Juventus to 10.12%. The firm ...
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...
Agri-biotech startup GreenGrahi has secured INR 32 Cr (around $3.7 Mn) in a seed funding round led by Avaana Capital ...
UK leads venture capital investment in Europe in Q1 2025, according to an update from KPMG. The report reveals latest VC ...
Emerging markets equities demonstrated resilience in Q1 against a backdrop of heightened geopolitical uncertainty and ...
Turning challenges into opportunities The biotech industry is facing multiple challenges ... high quality data and building data sets for AI models require significant investments. One key answer is ...
Wilson Community College is building a biotechnology and workforce center to prepare students for jobs in the biotech ...
Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...
Ascentage Pharma Group International’s AAPG share price has surged by 7.56%, which has investors questioning if this is right time to sell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results